Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ARV-393 |
Synonyms | |
Therapy Description |
ARV-393 is a proteolysis targeting chimera (PROTAC) targeting BCL6, which induces degradation of BCL6 and potentially inhibits tumor growth (Cancer Res (2024) 84 (7_Supplement): ND05) |